Typically required: company registration, GST/PAN, drug licence, import licence (if applicable), formulation dossier, packaging artwork, and a signed manufacturing agreement.
Yes. Their facility holds ISO 9001:2015, GMP, and WHO‑GMP certifications.
They offer cost‑effective, high-quality manufacturing with strict compliance, advanced facilities, diverse product lines, and tailored support.
Reach out via their website, email (newbusiness@systoleremedies.com), or phone (+91‑9828506600). They’ll guide you through product selection, formulation, agreement, & onboarding.
Timelines vary by product complexity and regulatory approvals, typically ranging from a few weeks to a couple of months.
Yes. Systole accommodates private‑label branding so you can market your products under your own label.
Yes. They assist with DCGI/CDSCO filings, obtaining drug licences and regulatory clearances.
Key advantages: no need for capital‑intensive facilities, faster time‑to‑market, cost savings, regulatory guidance and focus on branding.
Their state‑of‑the‑art WHO‑GMP plant is designed to fulfill large bulk orders at scale.
Through rigorous quality controls—raw material testing, in‑process checks, finished product validation, regular audits, staff training, and adherence to WHO‑GMP.
They combine top‑tier certifications, modern tech, diverse therapeutic ranges, strict compliance, flexible services and personalized partner support.
Email newbusiness@systoleremedies.com (or newbusiness2@systoleremedies.in), call +91‑9828506600 / 750‑8340‑032, or use the contact form on their website.
They produce tablets, capsules, syrups, dry syrups, injections, ophthalmic products, beta-lactam and non-beta-lactam drugs, as well as hormonal, cardiac, diabetic, neurological, and urological formulations.
Based in Ogli, Kala Amb, Sirmaur (Himachal Pradesh), they supply across India (and potentially export, on enquiry).
